Topic: Personalized medicine
The latest innovation from Roche’s Genentech targets cancer cells via video game to raise awareness of personalized medicine, tumor types and biomarker testing.
Sanofi talks up an individualized approach to diabetes care in a new awareness campaign called “Diabetes Your Type.”
Two senators have introduced a bill designed to encourage deals that would allow insurers to spread payments for expensive therapies over time.
England's cost-effectiveness watchdogs gave Novartis the go-ahead for its CAR-T drug, Kymriah, to treat leukemia.
The hyperpersonalization trend means pharmarketers are going to use advanced data and analytics to target audiences as small as one.
Kite's new CAR-T approval vaults it and new parent Gilead into a market first launched by Novartis—and into the debate over high drug prices.
One cancer patient is urging Novartis to weigh taxpayer investment in early-stage CAR-T science in setting a price on its new med tisagenlecleucel.
The highly valued yet mysterious Moderna provided a peek at its first human data, reporting positive interim results from a phase 1 trial testing its mRNA-based H10N8 flu vaccine.